Otilimab Begins Phase 3 Clinical Studies for RA

In a four-part clinical trial program, researchers are assessing the safety and efficacy of otilimab with placebo in RA patients, along side conventional treatments, such as tofacitinib, and DMARDs...

Source: The Rheumatologist - August 19, 2019 Category: Rheumatology Authors: Natasha Yetman Tags: DMARDs & Immunosuppressives Drug Updates biologic DMARD otilimab Rheumatoid Arthritis (RA) sarilumab Source Type: research